Skip to content

The Bad Seed: Mystical Experience and Time Travel in the Treatment of Psychopathy

Noelle Burton

Psychoanalytic Dialogues November 2, 2023 DOI: 10.1080/10481885.2023.2264338 via OpenAlex

Summary

AI-generated from the abstract

A man diagnosed with psychopathy made dramatic therapeutic improvements after a psilocybin-induced mystical experience during psychoanalysis. Key therapeutic factors included tactful confrontation of his behavior, disclosure of the diagnosis, focusing on his resentment toward existence, using mental time travel to imagine his future self, and the analyst's spiritual work shaping countertransference. The patient was able to use psychoanalytic work done before the mystical experience afterward. This case adds to evidence for psychedelic-induced mystical experiences and offers guidance on providing psychoanalytic treatment prior to psychedelic medication.

Study at a glance

Characteristics Case study Case report Peer reviewed
Sample size 1
Population A psychopathic personality
Intervention Psilocybin
Topics Mysticism
Keywords Psychoanalytic theory Psychology Psychotherapist Psychopathy
Citations 2
Key finding A psychopathic patient made dramatic improvements after a psilocybin-induced mystical experience combined with psychoanalytic treatment.

Abstract

Psychopathy has long been considered untreatable. The purpose of this paper is to provide a report from the field on therapeutic gains made in the case of a psychopathic personality and to outline what appear to be the most effective aspects of the treatment, as well as to help integrate current psychedelic research and theory with psychoanalytic theory. These therapeutic factors include: tactful acknowledgment and confrontation of the patient’s behavior and the disclosure to him of the diagnosis of psychopathy; a focus on his resentment toward existence itself; the cultivation of a relationship between the patient and his future self through the engagement of his imagination using mental time travel; the patient’s psilocybin-induced mystical experience which occurred several months into treatment; and finally, the impact of the analyst’s spiritual work that shaped the countertransference. The patient made dramatic improvements subsequent to his mystical experience, and was able to make use of the psychoanalytic work done during the “pre-mystical experience” period of his treatment. This case is an addition to the accumulating evidence for the efficacy of psychedelic-induced mystical experiences, and provides guidance on the provision of psychoanalytic treatment prior to treatment with psychedelic medication.

Explore topics

Comments

No comments yet.

Log in to comment